Dr. He is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Mayo Clinic
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Rong He is a pathologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. She received her medical degree from Hunan Medical University and has been in practice 17 years. She specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in myelodysplasia, leukemia, and bleeding and thrombotic disorders. She is the co-director of the Molecular Hematopathology Lab and has more than 100 publications and over 500 citings.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematopathology, 2010 - 2011
University of Wisconsin Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Hunan Medical UniversityClass of 1994
Certifications & Licensure
WI State Medical License 2008 - 2025
MN State Medical License 2010 - 2024- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 46 citationsBlinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysisCandace L. Haddox, Abhishek A. Mangaonkar, Dong Chen, Min Shi, Rong He
Blood Cancer Journal. 2017-09-15 - 313 citationsPembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy LaPlant, Timothy G. Call, Sameer A. Parikh, Jose F. Leis
Blood. 2017-06-29 - 6 citationsClinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study.Stephanie L Pritzl, Mark Gurney, Talha Badar, Alejandro Ferrer, Terra Lasho
Leukemia Research. 2023-02-01
Journal Articles
- Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid l...Rong He, Daniel J. Devin1, Zheng Jin Tu, Ming Mai, Dong Chen, Phuong L. Nguyen, Jennifer L. Oliveira, James D. Hoyer, Kaaren K. Reichard, Paul L. Ollila, Aref Al-Kali,..., Modern Pathology, 8/30/2019
- Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell LymphomaAndrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood
Abstracts/Posters
- Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504...Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be BeneficialRong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparison of _LEPRA and _LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family StudyRong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Current Status of Clinical Laboratory Testing of Plasma Cell Neoplasms: A Case-Based Approach61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
